Abstract:Ovarian cancer (OC) has the worst prognosis among all malignancy types in females worldwide according to epidemiological studies in 2017. Although radiotherapy, chemotherapy and surgical treatment are the most common treatment methods, their curative effects are not satisfactory. The present study aimed to examine the role of cluster of differentiation 44 variant 6 (CD44v6) in the molecular mechanism of the proliferation and tumorigenicity of OC cells, and provide a novel target for the clinical treatment of OC. A total of 46 clinical samples were collected, including 24 malignant ovarian tumor tissue samples and 22 benign ovarian tissue samples. Expression of CD44v6 and nuclear factor-κB (NF-κB) in these samples was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry. The A2780 OC cell line was used to establish a normal control group, a negative control group and a CD44v6-small interfering (si)RNA transfection group. The expression of CD44v6 and NF-κB mRNA was detected in each group by RT-qPCR. The proliferation, invasion and migration abilities of the cells were then assessed by Transwell and colony formation assays. Additionally, immunofluorescence was used to detect nuclear NF-κB expression. CD44v6 and NF-κB mRNA expression levels were significantly increased in malignant ovarian tumor tissues, compared with normal ovarian tissues (P<0.01), and immunohistochemistry demonstrated similar results. In the CD44v6-siRNA group, NF-κB mRNA expression was significantly reduced, compared with the control and negative control (both P<0.01) groups. Transwell and colony formation assays demonstrated that the migration, invasion and colony formation abilities of OC cells in the CD44v6-siRNA group were significantly reduced, compared with the control and negative control (both P<0.01) groups. Immunofluorescence results demonstrated that the expression of NF-κB in the cytoplasm and nucleus of the CD44v6-siRNA group was also markedly reduced, compared with the other two groups. In conclusion, CD44v6 may participate in the proliferation of OC cells through activation of the NF-κB pathway and these observations may provide a novel therapeutic target for the clinical treatment of OC.

CD44v6 promotes β-catenin and TGF-β expression, inducing aggression in ovarian cancer cells.

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1

CD44v6 May Influence Ovarian Cancer Cell Invasion and Migration by Regulating the NF-κB Pathway.

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

[Clinical Significance of CD44 Expression in Ovarian Epithelial Tumors].

The Expression of CD44v6 Mrna in Human Gastric Cancer

[Expression and Clinical Significance of Adhesive Molecule CD44v6 in Breast Invasive Ductal Carcinoma].

Cd44v6 Overexpression Related to Metastasis and Poor Prognosis of Colorectal Cancer: A Meta-Analysis

CD44v6 Down-Regulation is an Independent Prognostic Factor for Poor Outcome of Colorectal Carcinoma.

Evaluation of the Prognostic Value and Functional Roles of CD44v6 in Gastric Cancer

Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer

Overexpression of CD 44 and EpCAM may be associated with the initiation and progression of epithelial ovarian cancer

CD44 Variant 6 is Associated with Prostate Cancer Metastasis and Chemo-/Radioresistance.

WNT6 Participates in the Occurrence and Development of Ovarian Cancer by Upregulating/activating the Typical Wnt Pathway and Notch1 Signaling Pathway

Expression and clinical significance of CD44v6 in colorectal adenoma and cancer

Expression and Significance of C-erbB2,CD44v5 in Human Ovarian Cancer

CD44 and CD44v6 Are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies

CXXC5 Drove Inflammation and Ovarian Cancer Proliferation Via Transcriptional Activation of ZNF143 and EGR1

The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.

Cd44 Affects the Expression Level of Fos-Like Antigen 1 in Cervical Cancer Tissues